Learn more
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
Protecting Our Future
Five years to save 8 million lives: everything you need to know about Gavi’s Investment Opportunity
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
VACCINE PROFILES
Read series
KEY PUBLICATION
Investment Opportunity 2026–2030Download
LATEST
Progress report
News releases
Communication toolkits
4 February 2014
206,000 more girls to benefit from HPV vaccine with GAVI Alliance support
9 April 2008
Australia and Papua New Guinea launch efforts to crush deadly Hib disease in Pacific region
19 May 2009
Developing countries increasingly help finance purchase of life-saving vaccines
1 August 2008
First shot of pentavalent vaccine for the children of the Solomon Islands
10 March 2011
Co-financing of GAVI vaccines on the increase
1 December 2011
Small island states punch above their weight
29 October 2014
Australia commits AUD 50 million to support immunisation in developing countries in 2015
24 April 2015
Next five years vital for childhood immunisation - Gavi CEO
